Literature DB >> 1341461

Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.

D Pariente1, J M Anaya, B Combe, C Jorgensen, J M Emberger, J F Rossi, J Sany.   

Abstract

OBJECTIVES: To evaluate the prevalence, the incidence and clinical presentation of non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
METHODS: Sixty-two patients with primary Sjögren's syndrome were analyzed retrospectively in an open investigation.
RESULTS: Of 62 patients with primary Sjögren's syndrome, 4 of them (6.4%) developed non-Hodgkin's lymphoma (6.9 cases per 1000 per year). All of them were women. Non-Hodgkin's lymphoma always developed after the onset of primary Sjögren's syndrome with a time interval ranging from 3 to 27 years. Pathological findings showed two diffused mixed small and large cell cleaved lymphomas and two diffused large cell cleaved lymphomas. Three cases had extra-nodular localizations. All of these 4 patients are still alive and in complete remission 2 to 8 years after the diagnosis of non-Hodgkin's lymphoma.
CONCLUSION: This study confirms the association of non-Hodgkin's lymphoma in primary Sjögren's syndrome. These non-Hodgkin's lymphomas frequently had extra-nodal localizations. Good sensitivity to treatment, when necessary, provided good prognosis.

Entities:  

Mesh:

Year:  1992        PMID: 1341461

Source DB:  PubMed          Journal:  Eur J Med        ISSN: 1165-0478


  8 in total

1.  No advantage for chlorambucil maintenance therapy in gastric MALT lymphoma.

Authors:  James O Armitage
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

2.  Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.

Authors:  E Theander; G Henriksson; O Ljungberg; T Mandl; R Manthorpe; L T H Jacobsson
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

Review 3.  Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.

Authors:  Andreas V Goules; Athanasios G Tzioufas
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  Hyperprolactinaemia in primary Sjögren's syndrome.

Authors:  M A Gutiérrez; J M Anaya; E Scopelitis; G Citera; L Silveira; L R Espinoza
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

Review 5.  Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.

Authors:  X Mariette
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

6.  Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin's and non-Hodgkin lymphoma: a single center experience.

Authors:  Timucin Cil; Abdullah Altintas; Abdurrahman Isikdogan; Sabri Batun
Journal:  Int J Hematol       Date:  2009-05-27       Impact factor: 2.490

Review 7.  Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis.

Authors:  Maria B Nishishinya; Claudia A Pereda; Santiago Muñoz-Fernández; José M Pego-Reigosa; Iñigo Rúa-Figueroa; José-Luis Andreu; Mónica Fernández-Castro; José Rosas; Estibaliz Loza Santamaría
Journal:  Rheumatol Int       Date:  2014-06-05       Impact factor: 2.631

8.  MALT Lymphoma of Minor Salivary Glands in a Sjögren's Syndrome Patient: a Case Report and Review of Literature.

Authors:  Savvas Titsinides; Nikolaos Nikitakis; Evangelia Piperi; Alexandra Sklavounou
Journal:  J Oral Maxillofac Res       Date:  2017-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.